GeM-LR: Discovering predictive biomarkers for small datasets in vaccine studies
PLOS Computational Biology · 2024
DOI: 10.1371/journal.pcbi.1012581 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS Computational Biology, 2024. Verfasst von Lin Lin und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biostatistics and Bioinformatics, Duke University, Durham, North Carolina, United States of America. Hauptthemen laut MEDLINE: Biomarkers, Vaccines, Computational Biology. Die Arbeit nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, Bill and Melinda Gates Foundation, National Science Foundation.
Abstract (Originalsprache)
Despite significant progress in vaccine research, the level of protection provided by vaccination can vary significantly across individuals. As a result, understanding immunologic variation across individuals in response to vaccination is important for developing next-generation efficacious vaccines. Accurate outcome prediction and identification of predictive biomarkers would represent a significant step towards this goal. Moreover, in early phase vaccine clinical trials, small datasets are prevalent, raising the need and challenge of building a robust and explainable prediction model that can reveal heterogeneity in small datasets. We propose a new model named Generative Mixture of Logistic Regression (GeM-LR), which combines characteristics of both a generative and a discriminative model. In addition, we propose a set of model selection strategies to enhance the robustness and interpretability of the model. GeM-LR extends a linear classifier to a non-linear classifier without losing interpretability and empowers the notion of predictive clustering for characterizing data heterogeneity in connection with the outcome variable. We demonstrate the strengths and utility of GeM-LR by applying it to data from several studies. GeM-LR achieves better prediction results than other popular methods while providing interpretations at different levels.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Biostatistics and Bioinformatics, Duke University, Durham, North Carolina, United States of America.
- Center for Human Systems Immunology, Duke University, Durham, North Carolina, United States of America.
- Duke Human Vaccine Institute, Duke University, Durham, North Carolina, United States of America.
- Department of Surgery, Duke University, Durham, North Carolina, United States of America.
- Department of Integrative Immunobiology, Duke University, Durham, North Carolina, United States of America.
- Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America.
ORCID-Profile: Lin Lin, Kelly E Seaton
Förderung
- NIAID NIH HHS
- Bill and Melinda Gates Foundation
- National Science Foundation
Zitieren
APA
Lin, L., Spreng, R. L., Seaton, K. E., Dennison, S. M., Dahora, L. C., Schuster, D. J., Sawant, S., Gilbert, P. B., Fong, Y., Kisalu, N., Pollard, A. J., Tomaras, G. D., & Li, J. (2024). GeM-LR: Discovering predictive biomarkers for small datasets in vaccine studies. PLOS Computational Biology. https://doi.org/10.1371/journal.pcbi.1012581
Vancouver
Lin L, Spreng RL, Seaton KE, Dennison SM, Dahora LC, Schuster DJ, et al. GeM-LR: Discovering predictive biomarkers for small datasets in vaccine studies. PLOS Computational Biology. 2024. doi:10.1371/journal.pcbi.1012581
BibTeX
@article{Lin2024,
author = {Lin, Lin and Spreng, Rachel L and Seaton, Kelly E and Dennison, S Moses and Dahora, Lindsay C and Schuster, Daniel J and Sawant, Sheetal and Gilbert, Peter B and Fong, Youyi and Kisalu, Neville and Pollard, Andrew J and Tomaras, Georgia D and Li, Jia},
title = {GeM-LR: Discovering predictive biomarkers for small datasets in vaccine studies},
journal = {PLOS Computational Biology},
year = {2024},
doi = {10.1371/journal.pcbi.1012581}
}
EUVIMED